Compare PCVX & ADT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCVX | ADT |
|---|---|---|
| Founded | 2013 | 1874 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.4B |
| IPO Year | 2020 | 2017 |
| Metric | PCVX | ADT |
|---|---|---|
| Price | $58.11 | $6.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $98.33 | $8.38 |
| AVG Volume (30 Days) | 1.1M | ★ 9.7M |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.36% |
| EPS Growth | N/A | ★ 29.63 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $5,128,607,000.00 |
| Revenue This Year | N/A | $5.00 |
| Revenue Next Year | N/A | $3.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 4.70 |
| 52 Week Low | $28.09 | $6.41 |
| 52 Week High | $76.61 | $8.94 |
| Indicator | PCVX | ADT |
|---|---|---|
| Relative Strength Index (RSI) | 52.93 | 26.37 |
| Support Level | $42.30 | N/A |
| Resistance Level | $65.00 | $8.30 |
| Average True Range (ATR) | 3.08 | 0.22 |
| MACD | -0.53 | -0.13 |
| Stochastic Oscillator | 35.38 | 18.31 |
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
ADT Inc is a provider of security, interactive, and smart home solutions serving consumer and small business customers in the United States (U.S.). The Company conducts business under the ADT brand name.